(HealthDay)—Patients with acne vulgaris have significantly higher glycemic index and glycemic load levels and significantly lower serum adiponectin levels, according to a study published in the July issue of the Journal ...
Jun 23, 2016
0
4
People who suffer itching with no clear cause may have previously unrecognized immune system defects. In a small study of such patients, researchers from the Center for the Study of Itch at Washington University School of ...
May 27, 2016
0
147
(HealthDay)—For solid organ transplant recipients, azathioprine dose and duration of immunosuppression are associated with increased risk of lip cancer, according to a study published in the June issue of the Journal of ...
May 24, 2016
0
1
(HealthDay)—Despite the promise of an "easy and natural" treatment for skin cancer, home remedies such as black salve can actually make things worse, new research shows.
May 23, 2016
0
75
(HealthDay)—Individuals with previous nonmelanoma skin cancer (NMSC) are more likely to engage in certain sun protection behaviors than those without previous NMSC, according to a study published online May 16 in the Journal ...
May 23, 2016
0
0
In a review of 19 studies, researchers at Johns Hopkins say they can confirm a "strong association" between certain scalp-pulling hairstyles—many common among African-Americans—and the development of traction alopecia, ...
Apr 27, 2016
0
24
(HealthDay)—Simvastatin/ezetimibe does not appear to be beneficial for severe alopecia areata (AA) in a sample of 20 patients, according to a letter to the editor published in the May issue of the Journal of the American ...
Apr 27, 2016
0
3
(HealthDay)—Neither the American College of Rheumatology (ACR) nor the Systemic Lupus International Collaborating Clinics (SLICC) criteria distinguishes patients with subacute cutaneous lupus erythematosus (SCLE) with major ...
Apr 27, 2016
0
1
About half of Medicare patients who start taking biologic therapies for moderate to severe plaque psoriasis stop within a year, according to a new study led by researchers from the Perelman School of Medicine at the University ...
Apr 25, 2016
0
3
(HealthDay)—For patients with psoriasis, ustekinumab is more effective than tumor necrosis factor-α inhibitors, according to a study published in the May issue of the Journal of the American Academy of Dermatology.
Apr 22, 2016
0
11
